Disclosure Of Interests In Other Entities [Text Block]

BerGenBio - Filing #2615544

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	449,045,000 NOK	—	—	—	—	735,869,000 NOK	—	—	—	—	—
Non-current assets	1,191,000 NOK	—	—	—	—	2,332,000 NOK	—	—	—	—	—
Current liabilities	64,868,000 NOK	—	—	—	—	66,604,000 NOK	—	—	—	—	—
Non-current liabilities	942,000 NOK	—	—	—	—	1,367,000 NOK	—	—	—	—	—
Revenue	—	—	—	—	774,000 NOK	—	—	601,000 NOK	—	—	—
Profit (loss)	—	309,364,000 NOK	—	—	309,364,000 NOK	—	—	257,029,000 NOK	257,029,000 NOK	—	—
Comprehensive income	—	309,476,000 NOK	0 NOK	0 NOK	309,476,000 NOK	—	0 NOK	257,029,000 NOK	257,029,000 NOK	0 NOK	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	436,646,000 NOK	—	—	—	—	721,641,000 NOK	—	—	—	—	253,586,000 NOK
Tax expense (income)	—	—	—	—	0 NOK	—	—	0 NOK	—	—	—